Apoptosis in nonalcoholic fatty liver disease: diagnostic and therapeutic implications

Pathological increases in cell death in the liver as well as in peripheral tissues has emerged as an important mechanism involved in the development and progression of nonalcoholic fatty liver disease (NAFLD). An increase in hepatocyte cell death by apoptosis is typically present in patients with NAFLD and in experimental models of steatohepatitis, while an increase in adipocyte cell death in visceral adipose tissue may be an important mechanism triggering insulin resistance and hepatic steatosis. The two fundamental pathways of apoptosis, the extrinsic (death receptor-mediated) and intrinsic (organelle-initiated) pathways, are both involved. This article summarizes the current knowledge related to the distinct molecular and biochemical pathways of cell death involved in NAFLD pathogenesis. In particular, it will highlight the efforts for the development of both novel diagnostic and therapeutic strategies based on this knowledge.

[1]  A. Feldstein,et al.  Caspase 1-mediated regulation of fibrogenesis in diet-induced steatohepatitis , 2011, Laboratory Investigation.

[2]  A. Feldstein,et al.  An apoptosis panel for nonalcoholic steatohepatitis diagnosis. , 2011, Journal of hepatology.

[3]  A. Kahraman,et al.  Obesity Affects the Liver – The Link between Adipocytes and Hepatocytes , 2010, Digestion.

[4]  F. Berthier,et al.  A new composite model including metabolic syndrome, alanine aminotransferase and cytokeratin‐18 for the diagnosis of non‐alcoholic steatohepatitis in morbidly obese patients , 2010, Alimentary pharmacology & therapeutics.

[5]  M. Hussain,et al.  Serum Levels of CK18 M30 and Leptin Are Useful Predictors of Steatohepatitis and Fibrosis in Paediatric NAFLD , 2010, Journal of pediatric gastroenterology and nutrition.

[6]  S. Friedman,et al.  Reduced nicotinamide adenine dinucleotide phosphate oxidase 2 plays a key role in stellate cell activation and liver fibrogenesis in vivo. , 2010, Gastroenterology.

[7]  H. Thomas,et al.  Impact of pan-caspase inhibition in animal models of established steatosis and non-alcoholic steatohepatitis. , 2010, Journal of hepatology.

[8]  G. Gores,et al.  CHOP and AP-1 cooperatively mediate PUMA expression during lipoapoptosis. , 2010, American journal of physiology. Gastrointestinal and liver physiology.

[9]  G. Gores,et al.  Hepatocyte death: a clear and present danger. , 2010, Physiological reviews.

[10]  E. Schiff,et al.  Clinical trial: the efficacy and safety of oral PF‐03491390, a pancaspase inhibitor – a randomized placebo‐controlled study in patients with chronic hepatitis C , 2010, Alimentary pharmacology & therapeutics.

[11]  G. Gores,et al.  779 PF-03491390 PAN-CASPASE INHIBITOR DECREASES LIVER INJURY AND FIBROSIS IN A MURINE MODEL OF NON-ALCOHOLIC STEATOHEPATITIS (NASH) , 2010 .

[12]  R. Levine,et al.  84 SAFETY, TOLERABILITY AND PRELIMINARY ACTIVITY OF GS-9450, A SELECTIVE CASPASE INHIBITOR, IN PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS (NASH) , 2010 .

[13]  G. Musso,et al.  Noninvasive assessment of liver disease severity with liver fat score and CK‐18 in NAFLD: Prognostic value of liver fat equation goes beyond hepatic fat estimation , 2010, Hepatology.

[14]  A. Chervonsky,et al.  Deletion of Fas in adipocytes relieves adipose tissue inflammation and hepatic manifestations of obesity in mice. , 2010, The Journal of clinical investigation.

[15]  P. Schauer,et al.  Adipocyte Apoptosis, a Link between Obesity, Insulin Resistance, and Hepatic Steatosis* , 2009, The Journal of Biological Chemistry.

[16]  Vanessa S Teaberry,et al.  Pan‐caspase inhibitor VX‐166 reduces fibrosis in an animal model of nonalcoholic steatohepatitis , 2009, Hepatology.

[17]  A. Kahraman,et al.  Apoptosis is associated with CD36/fatty acid translocase upregulation in non‐alcoholic steatohepatitis , 2009, Liver international : official journal of the International Association for the Study of the Liver.

[18]  A. Feldstein,et al.  Cytokeratin‐18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: A multicenter validation study , 2009, Hepatology.

[19]  G. Gores,et al.  Mcl-1 Degradation during Hepatocyte Lipoapoptosis* , 2009, The Journal of Biological Chemistry.

[20]  A. Feldstein,et al.  Lipotoxicity in nonalcoholic fatty liver disease: not all lipids are created equal , 2009, Expert review of gastroenterology & hepatology.

[21]  G. Gores,et al.  Matrix metalloproteinase inhibitor, CTS‐1027, attenuates liver injury and fibrosis in the bile duct‐ligated mouse , 2009, Hepatology research : the official journal of the Japan Society of Hepatology.

[22]  G. Gores,et al.  JNK1-dependent PUMA Expression Contributes to Hepatocyte Lipoapoptosis* , 2009, The Journal of Biological Chemistry.

[23]  Lifen Gao,et al.  sTRAIL levels and TRAIL gene polymorphisms in Chinese patients with fatty liver disease , 2009, Immunogenetics.

[24]  Dong Wang,et al.  Reduced endoplasmic reticulum luminal calcium links saturated fatty acid-mediated endoplasmic reticulum stress and cell death in liver cells , 2009, Molecular and Cellular Biochemistry.

[25]  C. Nolan,et al.  Lipotoxicity: Why do saturated fatty acids cause and monounsaturates protect against it? , 2009, Journal of gastroenterology and hepatology.

[26]  A. Feldstein,et al.  566 An Apoptosis Panel for Nonalcoholic Steatohepatitis Diagnosis , 2009 .

[27]  D. Schuppan,et al.  The clinical utility of biomarkers and the nonalcoholic steatohepatitis CRN liver biopsy scoring system in patients with nonalcoholic fatty liver disease , 2009, Journal of gastroenterology and hepatology.

[28]  A. Feldstein,et al.  Hepatic Lipid Partitioning and Liver Damage in Nonalcoholic Fatty Liver Disease , 2009, Journal of Biological Chemistry.

[29]  G. Gores,et al.  A randomized, double-blinded, placebo-controlled multicenter trial of etanercept in the treatment of alcoholic hepatitis. , 2008, Gastroenterology.

[30]  A. Diehl,et al.  Mechanisms of disease progression in nonalcoholic fatty liver disease. , 2008, Seminars in liver disease.

[31]  P. Schauer,et al.  Cytokeratin 18 fragment levels as a noninvasive biomarker for nonalcoholic steatohepatitis in bariatric surgery patients. , 2008, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[32]  Ming Yan,et al.  Prevention of free fatty acid–induced hepatic lipotoxicity by 18β‐glycyrrhetinic acid through lysosomal and mitochondrial pathways , 2008, Hepatology.

[33]  A. Baranova,et al.  A Novel Diagnostic Biomarker Panel for Obesity-related Nonalcoholic Steatohepatitis (NASH) , 2008, Obesity surgery.

[34]  G. Gores,et al.  Cellular and molecular mechanisms of liver injury. , 2008, Gastroenterology.

[35]  G. Gores,et al.  The lysosomal‐mitochondrial axis in free fatty acid–induced hepatic lipotoxicity , 2008, Hepatology.

[36]  G. Gores,et al.  TRAIL mediates liver injury by the innate immune system in the bile duct–ligated mouse , 2008, Hepatology.

[37]  Ramesh Natarajan,et al.  Activation and dysregulation of the unfolded protein response in nonalcoholic fatty liver disease. , 2008, Gastroenterology.

[38]  D. A. Gomes,et al.  Apoptotic hepatocyte DNA inhibits hepatic stellate cell chemotaxis via toll‐like receptor 9 , 2007, Hepatology.

[39]  G. Gores,et al.  Death receptor-mediated liver injury. , 2007, Seminars in liver disease.

[40]  G. Gores,et al.  Transcriptional Regulation of Bim by FoxO3A Mediates Hepatocyte Lipoapoptosis* , 2007, Journal of Biological Chemistry.

[41]  G. Michalopoulos,et al.  Lack of Fas antagonism by Met in human fatty liver disease , 2007, Nature Medicine.

[42]  David Hecht,et al.  Oral IDN‐6556, an antiapoptotic caspase inhibitor, may lower aminotransferase activity in patients with chronic hepatitis C , 2007, Hepatology.

[43]  C. McClain,et al.  Good fat/bad fat , 2007, Hepatology.

[44]  S. McCall,et al.  Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis , 2007, Hepatology.

[45]  G. Gores,et al.  cFLIPL prevents TRAIL-induced apoptosis of hepatocellular carcinoma cells by inhibiting the lysosomal pathway of apoptosis. , 2007, American journal of physiology. Gastrointestinal and liver physiology.

[46]  G. Gores,et al.  Free fatty acids sensitise hepatocytes to TRAIL mediated cytotoxicity , 2007, Gut.

[47]  Dong Wang,et al.  Saturated fatty acid-mediated endoplasmic reticulum stress and apoptosis are augmented by trans-10, cis-12-conjugated linoleic acid in liver cells , 2007, Molecular and Cellular Biochemistry.

[48]  E. Ulukaya,et al.  Soluble forms of extracellular cytokeratin 18 may differentiate simple steatosis from nonalcoholic steatohepatitis. , 2007, World journal of gastroenterology.

[49]  S. Lipkowitz,et al.  TRAIL mediates apoptosis in cancerous but not normal primary cultured cells of the human reproductive tract , 2007, Apoptosis.

[50]  B. Sharma,et al.  Beneficial effects of pentoxifylline on hepatic steatosis, fibrosis and necroinflammation in patients with non‐alcoholic steatohepatitis , 2006, Journal of gastroenterology and hepatology.

[51]  A. Colell,et al.  Mitochondrial free cholesterol loading sensitizes to TNF- and Fas-mediated steatohepatitis. , 2006, Cell metabolism.

[52]  Dong Wang,et al.  Saturated fatty acids induce endoplasmic reticulum stress and apoptosis independently of ceramide in liver cells. , 2006, American journal of physiology. Endocrinology and metabolism.

[53]  Lisa M Yerian,et al.  In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease , 2006, Hepatology.

[54]  G. Gores,et al.  Bax inhibition protects against free fatty acid-induced lysosomal permeabilization. , 2006, American journal of physiology. Gastrointestinal and liver physiology.

[55]  G. Gores,et al.  Free Fatty Acids Induce JNK-dependent Hepatocyte Lipoapoptosis* , 2006, Journal of Biological Chemistry.

[56]  M. Pagliassotti,et al.  Saturated fatty acids promote endoplasmic reticulum stress and liver injury in rats with hepatic steatosis. , 2006, Endocrinology.

[57]  J. Olefsky,et al.  Inflamed fat: what starts the fire? , 2005, The Journal of clinical investigation.

[58]  G. Gores,et al.  Death by association: BH3 domain-only proteins and liver injury. , 2005, American journal of physiology. Gastrointestinal and liver physiology.

[59]  A. Feldstein,et al.  Nonalcoholic fatty liver disease in the pediatric population: a review , 2005, Current opinion in pediatrics.

[60]  G. Gores,et al.  Apoptosis in alcoholic and nonalcoholic steatohepatitis. , 2005, Frontiers in bioscience : a journal and virtual library.

[61]  J. Lemasters Dying a thousand deaths: redundant pathways from different organelles to apoptosis and necrosis. , 2005, Gastroenterology.

[62]  G. Gores,et al.  Apoptosis: a mechanism of acute and chronic liver injury , 2005, Gut.

[63]  D. Green,et al.  Apoptotic Pathways: Ten Minutes to Dead , 2005, Cell.

[64]  K. Wellen,et al.  Inflammation, stress, and diabetes. , 2005, The Journal of clinical investigation.

[65]  G. Gores,et al.  Cathepsin B inactivation attenuates hepatocyte apoptosis and liver damage in steatotic livers after cold ischemia-warm reperfusion injury. , 2005, American journal of physiology. Gastrointestinal and liver physiology.

[66]  D. Ron,et al.  CHOP induces death by promoting protein synthesis and oxidation in the stressed endoplasmic reticulum. , 2004, Genes & development.

[67]  K. Lindor,et al.  A Pilot Trial of Pentoxifylline in Nonalcoholic Steatohepatitis , 2004, The American Journal of Gastroenterology.

[68]  Yigong Shi,et al.  Molecular mechanisms of caspase regulation during apoptosis , 2004, Nature Reviews Molecular Cell Biology.

[69]  Xiao-Ming Yin,et al.  Dissection of the multiple mechanisms of TNF‐α‐induced apoptosis in liver injury , 2004 .

[70]  Takahiro Suzuki,et al.  Hepatocyte-specific disruption of Bcl-xL leads to continuous hepatocyte apoptosis and liver fibrotic responses. , 2004, Gastroenterology.

[71]  Amy S. Lee,et al.  Transgenic mouse model for monitoring endoplasmic reticulum stress in vivo , 2004, Nature Medicine.

[72]  H. Cortez‐Pinto,et al.  Hepatocyte Apoptosis, Expression of Death Receptors, and Activation of NF-κB in the Liver of Nonalcoholic and Alcoholic Steatohepatitis Patients , 2004, The American Journal of Gastroenterology.

[73]  L. Krugner-Higby,et al.  Mitochondria in nonalcoholic fatty liver disease. , 2004, Clinics in liver disease.

[74]  J. Horton,et al.  Molecular mediators of hepatic steatosis and liver injury. , 2004, The Journal of clinical investigation.

[75]  G. Gores,et al.  Free fatty acids promote hepatic lipotoxicity by stimulating TNF‐α expression via a lysosomal pathway , 2004 .

[76]  J. Kench,et al.  Beyond insulin resistance in NASH: TNF‐α or adiponectin? , 2004, Hepatology.

[77]  G. Gores,et al.  Lysosomes in cell death , 2004, Oncogene.

[78]  D. Pessayre,et al.  The ins and outs of mitochondrial dysfunction in NASH. , 2004, Diabetes & metabolism.

[79]  D. Bredesen,et al.  Coupling endoplasmic reticulum stress to the cell death program , 2004, Cell Death and Differentiation.

[80]  G. Gores,et al.  The Caspase Inhibitor IDN-6556 Attenuates Hepatic Injury and Fibrosis in the Bile Duct Ligated Mouse , 2004, Journal of Pharmacology and Experimental Therapeutics.

[81]  G. Gores,et al.  Apoptosis: The nexus of liver injury and fibrosis , 2004, Hepatology.

[82]  H. Horvitz,et al.  A first insight into the molecular mechanisms of apoptosis , 2004, Cell.

[83]  M. Desai,et al.  Obesity is associated with macrophage accumulation in adipose tissue. , 2003, The Journal of clinical investigation.

[84]  G. Gores,et al.  Diet associated hepatic steatosis sensitizes to Fas mediated liver injury in mice. , 2003, Journal of hepatology.

[85]  M. Diederich,et al.  An Introduction to the Molecular Mechanisms of Apoptosis , 2003, Annals of the New York Academy of Sciences.

[86]  Suzanne Cory,et al.  The Bcl-2 family: roles in cell survival and oncogenesis , 2003, Oncogene.

[87]  K. Valentino,et al.  First clinical trial of a novel caspase inhibitor: anti-apoptotic caspase inhibitor, IDN-6556, improves liver enzymes. , 2003, International journal of clinical pharmacology and therapeutics.

[88]  J. Eaton,et al.  Lysosomal enzymes promote mitochondrial oxidant production, cytochrome c release and apoptosis. , 2003, European journal of biochemistry.

[89]  G. Gores,et al.  Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis. , 2003, Gastroenterology.

[90]  J. Tschopp,et al.  Induction of TNF Receptor I-Mediated Apoptosis via Two Sequential Signaling Complexes , 2003, Cell.

[91]  G. Gores,et al.  Cathepsin B inactivation attenuates hepatic injury and fibrosis during cholestasis. , 2003, The Journal of clinical investigation.

[92]  G. Kroemer,et al.  Lysosomal Membrane Permeabilization Induces Cell Death in a Mitochondrion-dependent Fashion , 2003, The Journal of experimental medicine.

[93]  R. Kaufman,et al.  The unfolded protein response , 2003, Journal of Cell Science.

[94]  G. Gores,et al.  Apoptotic Body Engulfment by a Human Stellate Cell Line Is Profibrogenic , 2003, Laboratory Investigation.

[95]  M. MacFarlane TRAIL-induced signalling and apoptosis. , 2003, Toxicology letters.

[96]  A. Moser,et al.  Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease , 2003, Hepatology.

[97]  G. Gores,et al.  Fas enhances fibrogenesis in the bile duct ligated mouse: a link between apoptosis and fibrosis. , 2002, Gastroenterology.

[98]  S. Cory,et al.  The Bcl2 family: regulators of the cellular life-or-death switch , 2002, Nature Reviews Cancer.

[99]  G. Gores,et al.  Cathepsin B knockout mice are resistant to tumor necrosis factor-alpha-mediated hepatocyte apoptosis and liver injury: implications for therapeutic applications. , 2001, The American journal of pathology.

[100]  J. Crespo,et al.  Gene expression of tumor necrosis factor α and TNF‐receptors, p55 and p75, in nonalcoholic steatohepatitis patients , 2001 .

[101]  S. Itohara,et al.  Inhibition of matrix metalloproteinases blocks lethal hepatitis and apoptosis induced by tumor necrosis factor and allows safe antitumor therapy , 2001, Nature Medicine.

[102]  R. Youle,et al.  Bax and Bak Coalesce into Novel Mitochondria-Associated Clusters during Apoptosis , 2001, The Journal of cell biology.

[103]  Marcel Leist,et al.  Cathepsin B Acts as a Dominant Execution Protease in Tumor Cell Apoptosis Induced by Tumor Necrosis Factor , 2001, The Journal of cell biology.

[104]  J. Martinou,et al.  Bax Is Present as a High Molecular Weight Oligomer/Complex in the Mitochondrial Membrane of Apoptotic Cells* , 2001, The Journal of Biological Chemistry.

[105]  L. Ellerby,et al.  Lysosomal Protease Pathways to Apoptosis , 2001, The Journal of Biological Chemistry.

[106]  G. Gores,et al.  Cathepsin B contributes to TNF-alpha-mediated hepatocyte apoptosis by promoting mitochondrial release of cytochrome c. , 2000, The Journal of clinical investigation.

[107]  G. Gores,et al.  Apoptosis and liver disease. , 2000, The American journal of medicine.

[108]  F. Urano,et al.  Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1. , 2000, Science.

[109]  G. Gores,et al.  Apoptosis and the liver: A mechanism of disease, growth regulation, and carcinogenesis , 1999, Hepatology.

[110]  Z. Younossi,et al.  Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. , 1999, Gastroenterology.

[111]  Xiaodong Wang,et al.  Bid, a Bcl2 Interacting Protein, Mediates Cytochrome c Release from Mitochondria in Response to Activation of Cell Surface Death Receptors , 1998, Cell.

[112]  M. Peter,et al.  Two CD95 (APO‐1/Fas) signaling pathways , 1998, The EMBO journal.

[113]  M. Omary,et al.  Apoptosis Generates Stable Fragments of Human Type I Keratins* , 1997, The Journal of Biological Chemistry.

[114]  G. Gores,et al.  Cathepsin B contributes to bile salt-induced apoptosis of rat hepatocytes. , 1997, Gastroenterology.

[115]  G. Salvesen,et al.  Caspase Cleavage of Keratin 18 and Reorganization of Intermediate Filaments during Epithelial Cell Apoptosis , 1997, The Journal of cell biology.

[116]  J. Kos,et al.  Regulation of the activity of lysosomal cysteine proteinases by pH-induced inactivation and/or endogenous protein inhibitors, cystatins. , 1995, Biological chemistry Hoppe-Seyler.

[117]  C. Surawicz,et al.  Editorial: Clostridium difficile Infection: Yet Another Predictor of Poor Outcome in Cirrhosis , 2010, The American Journal of Gastroenterology.

[118]  M. Pagliassotti,et al.  Reduced endoplasmic reticulum luminal calcium links saturated fatty acid-mediated endoplasmic reticulum stress and cell death in liver cells , 2009, Molecular and Cellular Biochemistry.

[119]  G. Gores,et al.  Cathepsins as effector proteases in hepatocyte apoptosis , 2007, Cell Biochemistry and Biophysics.

[120]  M. Pinzani Liver fibrosis , 2004, Springer Seminars in Immunopathology.

[121]  S. Friedman,et al.  Liver fibrosis -- from bench to bedside. , 2003, Journal of hepatology.

[122]  M. Peter,et al.  The CD95(APO-1/Fas) DISC and beyond , 2003, Cell Death and Differentiation.

[123]  F. Schaffner,et al.  Nonalcoholic fatty liver disease. , 1986, Progress in liver diseases.